VX-702
VX-702 is an investigational oral small molecule with high specificity for p38α MAPK, showing 14-fold selectivity over p38β. It has been studied in clinical trials for rheumatoid arthritis and is used in research to investigate p38α signaling in inflammatory disease models, both in vitro and in vivo.
Product Specifications
CAS Number
745833-23-2
Product Name Alternative
VX 702, VX702, VX-702, Inhibitor, inhibit, p38 MAPK, p38α, p38MAPK, Autophagy, 479543-46-9
Field of Research
Cell Biology, Signal Transduction
Purity
>98%
Bioactivity
P38a MAP kinase inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 40 mg/ml) or in Ethanol (up to 2 mg/ml)
Smiles
NC (=O) N (c1ccc (C (N) =O) c (n1) -c1ccc (F) cc1F) c1c (F) cccc1F
Molecular Formula
C19H12F4N4O2
Molecular Weight
404.32
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
6-[ (Aminocarbonyl) (2,6-difluorophenyl) amino]-2- (2,4-difluorophenyl) -3-pyridinecarboxamide
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
